Question 1

What are the specific chemotherapy options available in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

Question 2

How does SU011248 compare to the chemotherapy treatments I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from SU011248 versus chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects from the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

Question 6

Can I continue with SU011248 if my cancer progresses but I am still responding well?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer clinical trial (NCT00246571). Contact the study team or your healthcare provider for specific answers.

What this study is about